Literature DB >> 9427393

The exoenzyme S regulon of Pseudomonas aeruginosa.

D W Frank1.   

Abstract

Pseudomonas aeruginosa can cause severe life-threatening infections in which the bacterium disseminates rapidly from epithelial colonization sites to the bloodstream. In experimental models, the ability of P. aeruginosa to disseminate is linked to epithelial injury, in vitro cytotoxicity and expression of the exoenzyme S regulon. Using the expression of ExoS as a model, a series of genes that are important for regulation, secretion and, perhaps, intoxication of eukaryotic cells have been identified. Proteins encoded by the exoenzyme S regulon and the Yersinia Yop virulon show a high level of amino acid homology, suggesting that P. aeruginosa may use a contact-mediated translocation mechanism to transfer anti-host factors directly into eukaryotic cells. Potential anti-host factors that may disrupt eukaryotic signal transduction through ADP-ribosylation include ExoS and ExoT. Expression of ExoU, another candidate anti-host factor, has been correlated with acute cytotoxicity and lung epithelial injury. Members of the exoenzyme S regulon represent only a portion of the virulence factor arsenal possessed by P. aeruginosa. It will be important to understand how the exoenzyme S regulon contributes to pathogenesis and whether these factors could serve as potential therapeutic targets.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9427393     DOI: 10.1046/j.1365-2958.1997.6251991.x

Source DB:  PubMed          Journal:  Mol Microbiol        ISSN: 0950-382X            Impact factor:   3.501


  155 in total

1.  Structure-function analysis of XcpP, a component involved in general secretory pathway-dependent protein secretion in Pseudomonas aeruginosa.

Authors:  S Bleves; M Gérard-Vincent; A Lazdunski; A Filloux
Journal:  J Bacteriol       Date:  1999-07       Impact factor: 3.490

2.  Differential sensitivity of human epithelial cells to Pseudomonas aeruginosa exoenzyme S.

Authors:  E M McGuffie; J E Fraylick; D J Hazen-Martin; T S Vincent; J C Olson
Journal:  Infect Immun       Date:  1999-07       Impact factor: 3.441

3.  Biological effects of Pseudomonas aeruginosa type III-secreted proteins on CHO cells.

Authors:  A J Vallis; V Finck-Barbançon; T L Yahr; D W Frank
Journal:  Infect Immun       Date:  1999-04       Impact factor: 3.441

4.  Involvement of the twin-arginine translocation system in protein secretion via the type II pathway.

Authors:  R Voulhoux; G Ball; B Ize; M L Vasil; A Lazdunski; L F Wu; A Filloux
Journal:  EMBO J       Date:  2001-12-03       Impact factor: 11.598

5.  PcrV immunization enhances survival of burned Pseudomonas aeruginosa-infected mice.

Authors:  I A Holder; A N Neely; D W Frank
Journal:  Infect Immun       Date:  2001-09       Impact factor: 3.441

6.  Pseudomonas aeruginosa ExoT is a Rho GTPase-activating protein.

Authors:  R Krall; G Schmidt; K Aktories; J T Barbieri
Journal:  Infect Immun       Date:  2000-10       Impact factor: 3.441

7.  Activation of the Pseudomonas aeruginosa type III secretion system requires an intact pyruvate dehydrogenase aceAB operon.

Authors:  Denis Dacheux; Olivier Epaulard; Arjan de Groot; Benoit Guery; Rozen Leberre; Ina Attree; Benoit Polack; Bertrand Toussaint
Journal:  Infect Immun       Date:  2002-07       Impact factor: 3.441

8.  O-antigen serotypes and type III secretory toxins in clinical isolates of Pseudomonas aeruginosa.

Authors:  Karine Faure; David Shimabukuro; Temitayo Ajayi; Leonard R Allmond; Teiji Sawa; Jeanine P Wiener-Kronish
Journal:  J Clin Microbiol       Date:  2003-05       Impact factor: 5.948

9.  The ADP ribosyltransferase domain of Pseudomonas aeruginosa ExoT contributes to its biological activities.

Authors:  L Garrity-Ryan; S Shafikhani; P Balachandran; L Nguyen; J Oza; T Jakobsen; J Sargent; X Fang; S Cordwell; M A Matthay; J N Engel
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

10.  Oligomerization of type III secretion proteins PopB and PopD precedes pore formation in Pseudomonas.

Authors:  Guy Schoehn; Anne Marie Di Guilmi; David Lemaire; Ina Attree; Winfried Weissenhorn; Andréa Dessen
Journal:  EMBO J       Date:  2003-10-01       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.